Table du jeu de données source : mopsfin_t187ap03_R
Date du tableau source : 1 nov. 2026· emerging
| Champ source | Valeur déclarée |
|---|---|
| AccountingFirm | 資誠聯合會計師事務所 |
| Address | 16F.-6, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115TAIPEI CITY 115, TAIWAN (R.O.C.) |
| CPA.CharteredPublicAccountant.First | 顏裕芳 |
| CPA.CharteredPublicAccountant.Second | 蔡蓓華 |
| Chairman | 黃文英 |
| CompanyAbbreviation | 安基生技 |
| CompanyName | 安基生技新藥股份有限公司 |
| Date | 1151101 |
| DateOfIncorporation | 20141215 |
| DateOfListing | 20240625 |
| DeputySpokesperson | 葉俊彥 |
| EmailAddress | [email protected] |
| Fax | (02)2365-8022 |
| GeneralManager | 黃文英 |
| IssueShares | 101130539 |
| Paidin.Capital.NTDollars | 1011305390 |
| ParValueOfCommonStock | 新台幣 10.0000元 |
| PreferredStock.shares | 0 |
| PreparationOfFinancialReportType | 2 |
| PrivateStock.shares | 0 |
| Registration | - |
| SecuritiesCompanyCode | 7754 |
| SecuritiesIndustryCode | 22 |
| Spokesman | 于怡文 |
24 champs sources sur 32 sont affichés.
Éléments de preuve de la source
BLAKE3 fcea56bf9444b6221ac3e2a42a06c62f782eacb4eee4788107e5ac361be8f9f2